Offering BBI’s expertise in the fight against Covid-19

As a worldwide market-leading provider of diagnostic reagents and rapid test/lateral flow contract services, BBI Solutions are dedicated to using our 35 years of expertise to help the fight against COVID-19

We are invested in providing business continuity at a time when our core mission, to 'Serve the Science of Diagnostics', has never been more critical.

At this exceptional time, BBI Solutions can and will help with;


Mobile test capture, interpretation and data dissemination using the Novarum™ mobile diagnostic solution

Novarum™ Mobile Diagnostic Platform

  • Improves the reliability of decentralised rapid testing by reducing user error and subjectivity
  • Enables epidemiological tracing due to data sharing and access
  • Direct communication channel to reinforce safe distancing measures and self-isolation
  • Applicable to all visual PoC platforms– agnostic on test format
Learn more

Capacity for lateral flow test manufacture for immunoassays

Lateral flow test manufactur for immunoassays

 

  • 120,000 sq. feet for manufacturing; ISO13485:2016 certified QMS system
  • Available for surge manufacture of your Covid-19 antigen or serology assays
  • Relieve capacity in your standard product portfolio manufacture to schedule Covid-19 assay production
  • R&D teams available to assist with validation of tests in development
Learn more

Gold Colloid and Conjugation


BBI is making its world-leading gold and conjugation services available to SARS-Cov-2 lateral flow assay developers at volumes and costs that remove any barriers to the expeditious roll-out of life-saving products

  • Custom Conjugation
  • Off the shelf conjugates
  • 40nm Human anti-IgM and anti-IgG gold conjugates 
  • Manufactured in-house for secure supply
  • Available for sampling today
Browse our conjugates

Critical reagents for rapid test development and production of Covid-19 assays

  • Anti-Human IgM and Anti-IgG antibodies, at scale for secure ongoing supply
  • 40nm Gold-conjugated Anti-IgM and Anti-IgG conjugates – off the shelf and ready to use
  • Industry-proven reagents, already standard in numerous clinical tests in market
  • Ancillary reagents for other critical care test requirements including antibodies and antigens for the diagnostic biomarker for acute inflammation marker, C-Reactive Protein (CRP)
Browse our secondary antibodies

We have compiled a page answering your frequently asked COVID-19 related questions on our website, which we will keep updated as the situation evolves. You can view these here:

https://bbisolutions.com/about-us/our-history/frequently-asked-questions-covid-19.html 

If you have any specific questions our Customer Services team will be happy to help you CustomerServices@the-bbigroup.com

Get in touch to see how we can support you in the fight against the global threat of COVID-19  https://bbisolutions.com/en/contact.html

 

 


Copyright © 2019 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS